Company Information
- Type:
- Company
- Country:
- Israel
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Publicly Listed
- Global Compact Status:
- Active
- Participant Since
- 01 March 2010 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 31 July 2025
Financial Information
Affiliated Subsidiaries
Country | Company Name |
---|---|
Croatia | Pliva Croatia Ltd. |
Communication On Progress
Published On | Title | Level/Status |
---|---|---|
08-Jul-2024 | 2024 Communication on Progress | Submitted |
15-May-2022 | ESG Progress Report | Advanced |
25-May-2021 | Communication on Progress | Advanced |
07-Sep-2020 | Communication on Progress | Learner |
18-Sep-2019 | Teva 2018 Social Impact Report | Active |
31-Oct-2018 | Teva 2017 Social Impact Report | Active |
24-Jan-2018 | Teva 2016 Social Impact Report | Active |
31-Mar-2017 | Teva 2015 Communication on Progress | Active |
10-Jan-2017 | Grace Letter | Not applicable |
05-Jan-2016 | Teva 2014 Global Citizenship Report | Active |
17-Dec-2014 | Teva 2013 CSR Report | Active |
16-Oct-2013 | Teva Pharmaceuticals CSR Report 2012 | Active |
16-Aug-2012 | Communication on Progress | Active |
26-Apr-2011 | 2011 Communication on Progress | Active |
16-Mar-2010 | 2010 Communication on Progress | Not applicable |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.